APA Zitierstil

Morikawa, A., Hayashi, T., Shimizu, N., Kobayashi, M., Taniue, K., Takahashi, A., . . . Akiyama, T. (2018). PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma. Oncotarget.

Chicago Zitierstil

Morikawa, Asuka, et al. "PIK3CA and KRAS Mutations in Cell Free Circulating DNA Are Useful Markers for Monitoring Ovarian Clear Cell Carcinoma." Oncotarget 2018.

MLA Zitierstil

Morikawa, Asuka, et al. "PIK3CA and KRAS Mutations in Cell Free Circulating DNA Are Useful Markers for Monitoring Ovarian Clear Cell Carcinoma." Oncotarget 2018.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.